BioSpace News Archive

Business

Large Gaps in Life Expectancy in Major U.S. Cities Linked to Racial/Ethnic Segregation by Neighborhood

Among the 500 largest U.S. cities, 56 have very large life expectancy gaps between census tracts, where on average people in one neighborhood can expect to live 20 to 30 years longer than their neighbors a few miles away.

June 5, 2019
·
5 min read
Business

BIO International Convention Begins Day Three with Jamie Dimon Keynote Address

Wednesday programming will feature timely discussions on diversity, inclusion and R&D investment

June 5, 2019
·
3 min read
Business

Ergomed Strengthens Executive Team with Appointment of Richard Barfield, Formerly of Chiltern International, as Chief Financial Officer

Ergomed plc (LSE: ERGO) (“Ergomed” or the “Company”), a company focused on providing specialised services to the pharmaceutical industry, today announces the appointment of Richard Barfield FCA as Chief Financial Officer, effective immediately.

June 5, 2019
·
3 min read
Kymab Presents Poster Detailing Adaptive Phase 1/2 Clinical Trial for its KY1044 Anti-ICOS Program at ASCO 2019 Annual Meeting

Kymab, a clinical-stage biopharmaceutical company developing antibody-based therapeutics, todayannounced a poster presentation detailing updates on the ongoing clinical trial of the company’s anti-ICOS program KY1044 at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting.

June 5, 2019
·
4 min read
Business

QIAGEN and DiaSorin collaborate on novel QuantiFERON-based test with breakthrough potential for earlier detection of Lyme disease

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE MIB: DIA) today announced the expansion of their QuantiFERON collaboration to develop an ultra-sensitive diagnostic test for Lyme disease, which is expected to address a significant unmet medical need.

June 5, 2019
·
2 min read
FDA

Sierra Announces Momelotinib Granted FDA Fast Track Designation

Sierra Oncology, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to momelotinib, a JAK1, JAK2 and ACVR1 inhibitor, for the treatment of patients with intermediate/high-risk myelofibrosis who have previously received a JAK inhibitor.

June 5, 2019
·
8 min read
Business

Conventus Orthopaedics Announces Rick Epstein as New CEO

Conventus Orthopaedics, Inc. announced that Rick Epstein will join the company as its new Chief Executive Officer, effective immediately.

June 5, 2019
·
1 min read
Pharm Country

Lannett Announces Initiation Of Human Clinical Trial Of Biosimilar Insulin Glargine Versus Us Lantus®

Lannett Company, Inc. announced the commencement of a human clinical trial of biosimilar insulin glargine, a product the company is co-developing with its strategic alliance partners within the HEC Group of companies.

June 5, 2019
·
2 min read
Drug Development

Amgen Announces First Clinical Data Evaluating Investigational KRAS(G12C) inhibitor AMG 510 at ASCO 2019

Amgen announced the first clinical results from a Phase 1 study evaluating investigational AMG 510, the first KRASG12C inhibitor to reach the clinical stage.

June 5, 2019
·
8 min read
Essity Sets Additional Sustainability Targets for Packaging

The global hygiene and health company Essity has set additional packaging targets aimed at reducing its environmental footprint.

June 5, 2019
·
1 min read